| |
| |
|
| Insider
Information: |
Hindman Andrew A. |
| Relationship: |
|
| City: |
Ardsley |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
400,353 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,516,442 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
400,353 |
|
|
| Total
Value |
$3,516,442 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -8.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief Business Officer |
2019-03-08 |
15,639 |
2014-05-13 |
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2022-11-20 |
384,714 |
2019-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
SVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-11-20 |
4 |
D |
$10.85 |
$271,868 |
D/D |
(25,057) |
384,714 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-11-18 |
4 |
S |
$11.02 |
$716,242 |
D/D |
(65,000) |
409,771 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-08-19 |
4 |
D |
$9.34 |
$239,814 |
D/D |
(25,676) |
473,507 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
499,183 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-05-20 |
4 |
D |
$8.74 |
$29,410 |
D/D |
(3,365) |
479,183 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-02-18 |
4 |
D |
$9.61 |
$249,601 |
D/D |
(25,973) |
481,285 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2021-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
340,000 |
507,258 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2021-08-20 |
4 |
D |
$14.05 |
$245,369 |
D/D |
(17,464) |
167,380 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2021-05-20 |
4 |
D |
$17.80 |
$16,768 |
D/D |
(942) |
184,844 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2021-02-20 |
4 |
D |
$18.79 |
$74,859 |
D/D |
(3,984) |
184,704 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
188,688 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2020-08-20 |
4 |
D |
$18.22 |
$78,765 |
D/D |
(4,323) |
123,135 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2020-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
127,458 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2020-02-20 |
4 |
D |
$25.90 |
$182,854 |
D/D |
(7,060) |
106,490 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
63,550 |
113,550 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Officer |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,045 |
15,639 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Officer |
• – – |
2019-02-21 |
4 |
D |
$13.38 |
$11,734 |
D/D |
(877) |
6,594 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Officer |
• – – |
2018-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
7,471 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Officer |
• – – |
2018-12-03 |
4 |
AS |
$20.56 |
$15,478 |
D/D |
(753) |
5,171 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Officer |
• – – |
2018-11-05 |
4 |
D |
$20.28 |
$17,826 |
D/D |
(879) |
5,924 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Officer |
• – – |
2018-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
6,803 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Officer |
• – – |
2018-05-25 |
4 |
S |
$24.26 |
$1,034,006 |
D/D |
(42,615) |
4,503 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Officer |
• – – |
2018-05-13 |
4 |
D |
$24.35 |
$95,696 |
D/D |
(3,930) |
47,118 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Business Dev. Officer |
• – – |
2018-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,742 |
51,048 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
